Huron Consulting Group Inc. (NASDAQ:HURN) Shares Sold by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL cut its holdings in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 66.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,211 shares of the business services provider's stock after selling 8,251 shares during the period. Tudor Investment Corp ET AL's holdings in Huron Consulting Group were worth $523,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of HURN. Aquatic Capital Management LLC bought a new stake in Huron Consulting Group during the 4th quarter valued at approximately $362,000. Susquehanna Fundamental Investments LLC bought a new position in shares of Huron Consulting Group during the 4th quarter valued at approximately $1,777,000. Two Sigma Securities LLC bought a new position in shares of Huron Consulting Group during the 4th quarter valued at approximately $209,000. Price T Rowe Associates Inc. MD boosted its position in shares of Huron Consulting Group by 3.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 19,264 shares of the business services provider's stock valued at $2,394,000 after acquiring an additional 596 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in shares of Huron Consulting Group by 27.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider's stock valued at $71,000 after acquiring an additional 122 shares during the last quarter. Institutional investors own 93.90% of the company's stock.

Insider Transactions at Huron Consulting Group

In other Huron Consulting Group news, CEO C. Mark Hussey sold 27,672 shares of the business's stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $145.91, for a total transaction of $4,037,621.52. Following the transaction, the chief executive officer now owns 81,118 shares of the company's stock, valued at approximately $11,835,927.38. The trade was a 25.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director John Mccartney sold 500 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $151.13, for a total value of $75,565.00. Following the transaction, the director now directly owns 55,688 shares in the company, valued at $8,416,127.44. This trade represents a 0.89% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 76,239 shares of company stock valued at $11,168,801 over the last ninety days. Insiders own 2.15% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on HURN. Truist Financial boosted their target price on Huron Consulting Group from $165.00 to $180.00 and gave the company a "buy" rating in a research report on Tuesday, March 4th. StockNews.com lowered Huron Consulting Group from a "buy" rating to a "hold" rating in a research note on Friday, May 2nd. Benchmark reiterated a "buy" rating and issued a $165.00 target price on shares of Huron Consulting Group in a research note on Wednesday, March 26th. William Blair reissued an "outperform" rating on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Finally, Barrington Research increased their price target on Huron Consulting Group from $167.00 to $173.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Huron Consulting Group currently has a consensus rating of "Moderate Buy" and an average price target of $170.75.

Huron Consulting Group Stock Down 1.7%

NASDAQ HURN traded down $2.50 during trading on Wednesday, hitting $147.31. The company's stock had a trading volume of 51,614 shares, compared to its average volume of 149,006. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. The company has a market cap of $2.54 billion, a PE ratio of 32.02 and a beta of 0.23. The business's 50 day simple moving average is $143.38 and its 200-day simple moving average is $131.94. Huron Consulting Group Inc. has a fifty-two week low of $84.87 and a fifty-two week high of $155.00.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The business services provider reported $1.68 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.52. The company had revenue of $404.14 million during the quarter, compared to analysts' expectations of $389.27 million. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. Huron Consulting Group's quarterly revenue was up 11.2% on a year-over-year basis. During the same period last year, the business earned $1.23 earnings per share. On average, equities analysts anticipate that Huron Consulting Group Inc. will post 6.1 EPS for the current fiscal year.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.